Evofem Biosciences, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 50.8% | -2,023.3% | -2,489.0% |
| FY2022 | 73.8% | -499.6% | -455.5% |
| FY2023 | 64.3% | -98.0% | 290.8% |
| FY2024 | 80.2% | -39.6% | -45.8% |
| FY2025 | 77.1% | 16.7% | 1.9% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 50.8% | -2,023.3% | -2,489.0% |
| FY2022 | 73.8% | -499.6% | -455.5% |
| FY2023 | 64.3% | -98.0% | 290.8% |
| FY2024 | 80.2% | -39.6% | -45.8% |
| FY2025 | 77.1% | 16.7% | 1.9% |